Thyroid Function Test Market Regional Analysis

Thyroid Function Test Market size was valued at USD 1.39 Billion in 2023 and is poised to grow from USD 1.54 Billion in 2024 to USD 3.55 Billion by 2032, growing at a CAGR of 11% during the forecast period (2025-2032).

To gain a strong foothold in the market, these players are focusing on a variety of strategies such as mergers, acquisitions, and product development. DiaSorin SpA, Abbott, F. Hoffmann-La Roche, Autobio Diagnostics, Kronus, Biomerieux SA, Siemens Healthineers, Qualigen Inc., Danaher Corporation, Thermo Fisher Scientific Inc., and others are among the market's major players. 'Thermo Fisher Scientific (US) ', 'Abbott Laboratories (US) ', 'Roche Diagnostics (Switzerland) ', 'Danaher Corporation (US) ', 'DiaSorin (Italy) ', 'Siemens Healthineers (Germany) ', 'Merck KGaA (Germany) ', 'Bio-Rad Laboratories (US) ', 'Ortho Clinical Diagnostics (US) ', 'Beckman Coulter (US) ', 'F. Hoffmann-La Roche Ltd. (Switzerland) ', 'QuidelOrtho (US) ', 'Inova Diagnostics (US) ', 'Sekisui Diagnostics (US) ', 'Trinity Biotech (Ireland) ', 'ARUP Laboratories (US) ', 'Quest Diagnostics (US) ', 'Laboratory Corporation of America Holdings (US) ', 'Eurofins Scientific (Luxembourg) ', 'MSD (Merck & Co.) (US)'

The thyroid function tests market is expected to be driven by the increasing prevalence of thyroid cancers and the unmet need for cost-effective tests for the detection of thyroid disorders. 

Focus on point-of-care testing: The point-of-care testing for thyroid function has gained a huge momentum for its convenience and rapid test results. These tests enable immediate diagnosis and monitoring of thyroid disorders.

The global thyroid function test market is studied on the basis of geography as North America, Europe, Asia-Pacific, South America, and Middle East & Africa. North America is expected to dominate the global thyroid function test market. This expansion is primarily due to the region’s regulatory bodies’ increasing approval of various tests and treatments. The growing awareness of innovative tests for the diagnosis of thyroid disorders in Europe is expected to fuel the thyroid function test market during the forecast period.The evolving healthcare infrastructure and growing patient population in Asia Pacific and Latin America are expected to drive thyroid function tests market growth during the forecast period. Furthermore, unmet needs for early detection of thyroid cancers are expected to drive growth in the Middle East and Africa thyroid function test market. Asia Pacific market is expected to grow at the fastest CAGR during the forecast period. This expansion can be attributed to factors such as the presence of a large target patient population, rising middle-class disposable income, and improved healthcare infrastructure in emerging countries such as China and India.